STAT5A and chronic myelogenous leukemia, BCR-ABL1 positive: However, treatment of CML using IM was found to potentiate CML towards leukemogenesis as it was reported that it enhances expression of hTERT via phosphorylation of STAT5 [90] (Figure 2).